FDA expedites approval of two new breast cancer treatments
The FDA has approved two new kinds of breast cancer treatments, one targeting HER2-positive cancers and a second for metastatic triple-negative breast cancer. The approval for both treatments was expedited due to the novel coronavirus pandemic. Source of Article